Exclusive

Publication

Byline

Location

US Patent Issued to Vanda Pharmaceuticals on Sept. 8 for "Methods of treating multiple sclerosis" (Canadian, American Inventors)

ALEXANDRIA, Va., Sept. 8 -- United States Patent no. 12,728,116, issued on Sept. 8, was assigned to Vanda Pharmaceuticals Inc. (Washington). "Methods of treating multiple sclerosis" was invented by A... Read More


US Patent Issued to Dermira on Sept. 8 for "MrgprX2 antagonists for the treatment of inflammatory disorders" (California Inventors)

ALEXANDRIA, Va., Sept. 8 -- United States Patent no. 12,728,117, issued on Sept. 8, was assigned to Dermira Inc. (Menlo Park, Calif.). "MrgprX2 antagonists for the treatment of inflammatory disorders... Read More


US Patent Issued to The Schepens Eye Research Institute on Sept. 8 for "Methods and compositions for the treatment of corneal endothelium disorders" (Massachusetts Inventor)

ALEXANDRIA, Va., Sept. 8 -- United States Patent no. 12,728,118, issued on Sept. 8, was assigned to The Schepens Eye Research Institute Inc. (Boston). "Methods and compositions for the treatment of c... Read More


US Patent Issued to NEW CANCER CURE-BIO on Sept. 8 for "Pharmaceutical composition for preventing or treating cancer comprising 3-ketoacyl CoA thiolase inhibitor and carnitine acylcarnitine carrier inhibitor" (South Korean Inventor)

ALEXANDRIA, Va., Sept. 8 -- United States Patent no. 12,728,119, issued on Sept. 8, was assigned to NEW CANCER CURE-BIO Co. LTD. (Goyang-si, South Korea). "Pharmaceutical composition for preventing o... Read More


US Patent Issued to Dr. Noah Biotech on Sept. 8 for "Prevention or treatment of brain disease and adverse effects of cholinesterase inhibitors" (South Korean Inventors)

ALEXANDRIA, Va., Sept. 8 -- United States Patent no. 12,728,120, issued on Sept. 8, was assigned to Dr. Noah Biotech Inc. (Suwon-si, South Korea). "Prevention or treatment of brain disease and advers... Read More


US Patent Issued to Seyltx on Sept. 8 for "Compositions and methods for treating idiopathic pulmonary fibrosis" (California Inventor)

ALEXANDRIA, Va., Sept. 8 -- United States Patent no. 12,728,121, issued on Sept. 8, was assigned to Seyltx Inc. (Pittsburgh). "Compositions and methods for treating idiopathic pulmonary fibrosis" was... Read More


US Patent Issued to ENB Therapeutics on Sept. 8 for "Treatment of urothelial and kidney cancers by use of endothelin B receptor antagonists" (New York Inventor)

ALEXANDRIA, Va., Sept. 8 -- United States Patent no. 12,728,122, issued on Sept. 8, was assigned to ENB Therapeutics Inc. (New York). "Treatment of urothelial and kidney cancers by use of endothelin ... Read More


US Patent Issued to Sesh Products on Sept. 8 for "Product" (Swedish Inventors)

ALEXANDRIA, Va., Sept. 8 -- United States Patent no. 12,728,123, issued on Sept. 8, was assigned to Sesh Products Inc. (Vancouver, Canada). "Product" was invented by Frank Svandal (Gothenburg, Sweden... Read More


US Patent Issued to BOREALIS on Sept. 8 for "Medical use of cystic fibrosis transmembrane conductance regulator (CFTR) modulators" (German Inventors)

ALEXANDRIA, Va., Sept. 8 -- United States Patent no. 12,728,124, issued on Sept. 8, was assigned to BOREALIS GMBH (Vienna). "Medical use of cystic fibrosis transmembrane conductance regulator (CFTR) ... Read More


US Patent Issued to X4 Pharmaceuticals on Sept. 8 for "Methods for treating neutropenia" (Massachusetts Inventors)

ALEXANDRIA, Va., Sept. 8 -- United States Patent no. 12,728,125, issued on Sept. 8, was assigned to X4 Pharmaceuticals Inc. (Boston). "Methods for treating neutropenia" was invented by E. Lynne Kelle... Read More